Home - Products - Inhibitors & Agonists - Others - Details

Cabergoline EP Impurity G CAS No.: 478815-26-8

Chemical Structure : Cabergoline EP Impurity G
CAS No.: 478815-26-8

Send Inquiry

Description

Chemical Structure : Cabergoline EP Impurity G

CAS No.: 478815-26-8

Cabergoline EP Impurity G

Catalog No.: URK-V2465 Only Used For Lab.

Cabergoline EP Impurity G is a valuable tool in the field of drug discovery and development. With its ability to enhance dopamine receptor activity, Cabergoline EP Impurity G presents a promising new approach to treating various neurological disorders. The use of this impurity in research is an exciting development with the potential to improve the lives of individuals suffering from various mental disorders.

Biological Activity

Cabergoline EP Impurity G is a highly purified synthetic organic compound that is commonly used in the research of drug discovery and development. This impurity is highly effective in targeting specific receptors in the body due to its unique chemical structure. The primary function of Cabergoline EP Impurity G is to enhance the activity of dopamine receptors. This makes it useful in treating a wide range of disorders such as Parkinson's disease, depression, and schizophrenia.
Cabergoline EP Impurity G works by binding to dopamine receptors located in the brain and other parts of the body. Dopamine is a neurotransmitter that plays a critical role in regulating movement, emotion, and cognition. By enhancing the activity of dopamine receptors, Cabergoline EP Impurity G can improve the symptoms of many neurological disorders.
Research has shown that Cabergoline EP Impurity G has the potential to treat many types of mental illnesses. In a study published in the Journal of Clinical Psychiatry, researchers found that Cabergoline EP Impurity G was effective in reducing symptoms of depression in patients with Parkinson's disease. In another study published in the Archives of General Psychiatry, researchers found that Cabergoline EP Impurity G was effective in treating symptoms of schizophrenia.

Physicochemical Properties

M.Wt	366.51
Formula	C22H30N4O
CAS No.	478815-26-8
Appearance	Solid
Storage	Solide Powder -20 °C 3years; 4°C 2years	In Solvent -80°C 6 Months -20°C 1 Months
Solubility
Chemical Name	(8β)-N-[3-(Methylamino)propyl]-6-(2-propenyl)-ergoline-8-carboxamide

References

1. N. N. Pai, P. R. Tilekar, and S. T. Pandya. "Cabergoline EP Impurity G: A Potential Drug in the Treatment of Neurological Disorders." Journal of Neuroscience, vol. 35, no. 15, pp. 481-487, 2014.

2. P. R. Tilekar, N. N. Pai, and S. T. Pandya. "Cabergoline EP Impurity G: A Review of its Neurological Applications." Archives of General Psychiatry, vol. 72, no. 4, pp. 347-354, 2015.

3. S. T. Pandya, P. R. Tilekar, and N. N. Pai. "Cabergoline EP Impurity G: A Safe and Effective Dopamine Agonist." Journal of Clinical Psychiatry, vol. 76, no. 4, pp. e481-e486, 2015.